PharmaLive (press release) (subscription) ... Afinitor is approved for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2 negative breast cancer (advanced HR+/HER2 negative) in combination with exemestane after failure of treatment with letrozole or anastrozole ...
4-traders (press release) ... Afinitor is approved for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2 negative breast cancer (advanced HR+/HER2 negative) in combination with exemestane after failure of treatment with letrozole or anastrozole ... and more »
Irish Medical Times ... into typical or first-generation (chlorpromazine, fluphenazine droperidol, haloperidol, flupenthixol), atypical or second-generation (clozapine risperidone, olanzapine , amisulpride, quetiapine) and dopamine partial agonists or third-generation ...
